Pfizer, BioNTech not sure on vaccines' effectiveness on new COVID variant 'Omicron'
The companies also promised to develop a new vaccine against the variant in about 100 days, Sputnik reported.
Full Article
Pfizer, BioNTech not sure on vaccines' effectiveness on new COVID variant 'Omicron'
DNA
0 shares
1 views
You might like
Related news coverage
FDA Calls for Fall COVID Boosters To Target Omicron Subvariants
Wibbitz Top Stories
FDA Calls for Fall COVID Boosters , To Target Omicron Subvariants.
NBC News reports that on June 30,
the Food and Drug..
Pfizer Says Updated COVID-19 Shot Effective Against Omicron
Wibbitz Top Stories
Advertisement
More coverage
Pres. Biden Says New Variant Cause For Concern, Not Panic In U.S.
Newsy
Watch VideoPresident Joe Biden called the new coronavirus variant omicron a cause for concern but "not a cause for panic" Monday..
-
Moderna CEO casts doubts on vaccine efficacy for Omicron Covid variant: Oil slumps and jittery Asian markets down
City A.M.
-
New variant may force drug companies to tweak Covid vaccination plans
IndiaTimes
-
News24.com | Omicron variant: Pfizer partner can have a vaccine ready in 100 days
News24
-
Moderna: Modified COVID vaccine for Omicron could be out by early 2022
Upworthy